NIKAOTCPharmaceutical PreparationsFiscal year ends December 31

NIKA PHARMACEUTICALS, INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$0.41+0.00 (0.00%)

Close on Oct 16, 2026

Market cap: $431.19M
P/E (TTM): –
Dividend yield: –

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Nika Pharmaceuticals has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Nika Pharmaceuticals filed with the SEC

Oct 16, 2024
FORM 8-K
Event dated Oct 2, 2024, from SEC EDGAR
Oct 1, 2024
FORM 8-K
Event dated Sep 23, 2024, from SEC EDGAR
Aug 27, 2024
FORM 8-K
Event dated Aug 18, 2024, from SEC EDGAR
May 10, 2024
FORM 8-K
Event dated Apr 23, 2024, from SEC EDGAR
Apr 15, 2024
FORM 8-K
Event dated Apr 10, 2024, from SEC EDGAR
Mar 5, 2024
FORM 8K
Event dated Mar 1, 2024, from SEC EDGAR
Feb 16, 2024
FORM 8-K
Event dated Feb 14, 2024, from SEC EDGAR
Sep 18, 2023
FORM 8-K
Event dated Sep 18, 2023, from SEC EDGAR
Nov 15, 2022
FORM 8-K
Event dated Nov 12, 2022, from SEC EDGAR
Nov 1, 2022
FORM 8-K
Event dated Oct 31, 2022, from SEC EDGAR
Aug 22, 2022
FORM 8-K
Event dated Aug 22, 2022, from SEC EDGAR
Apr 12, 2022
FORM 8-K
Event dated Apr 12, 2022, from SEC EDGAR
Apr 5, 2022
FORM 8-K
Event dated Apr 5, 2022, from SEC EDGAR